Interleukin-2/antibody complex expanding Foxp3＋ regulatory T cells exacerbates Th2-mediated allergic airway inflammation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Foxp3＋ regulatory CD4＋ T (Treg) cells play an essential role in preventing overt immune responses against self and innocuous foreign antigens. Selective expansion of endogenous Treg cells in response to the administration of interleukin (IL)-2/antibody complex, such as the IL-2/JES6-1 complex (IL-2C) in mice, is considered an attractive therapeutic approach to various immune disorders. Here, we investigated the therapeutic potential of IL-2C in allergic airway inflammation models. IL-2C treatment ameliorated Th17-mediated airway inflammation; however, unexpectedly, IL-2C treatment exacerbated Th2-mediated allergic airway inflammation by inducing the selective expansion of Th2 cells and type-2 innate lymphoid cells. We also found that IL-2 signaling is required for the expansion of Th2 cells in lymphoproliferative disease caused by Treg cell depletion. Our data suggest that IL-2C is selectively applicable to the treatment of allergic airway diseases depending on the characteristics of airway inflammation.
Abstract
Foxp3＋ regulatory CD4＋ T (Treg) cells play an essential role in preventing overt immune responses against self and innocuous foreign antigens. Selective expansion of endogenous Treg cells in response to the administration of interleukin (IL)-2/antibody complex, such as the IL-2/JES6-1 complex (IL-2C) in mice, is considered an attractive therapeutic approach to various immune disorders. Here, we investigated the therapeutic potential of IL-2C in allergic airway inflammation models. IL-2C treatment ameliorated Th17-mediated airway inflammation; however, unexpectedly, IL-2C treatment exacerbated Th2-mediated allergic airway inflammation by inducing the selective expansion of Th2 cells and type-2 innate lymphoid cells. We also found that IL-2 signaling is required for the expansion of Th2 cells in lymphoproliferative disease caused by Treg cell depletion. Our data suggest that IL-2C is selectively applicable to the treatment of allergic airway diseases depending on the characteristics of airway inflammation.
참고문헌 (28)
- Josefowicz SZ, "Regulatory T cells : mechanisms of differentiation and function", Annu Rev Immunol, 30, pp.531~564 (2012)
- Noval Rivas M, "Regulatory T cells in allergic diseases", J Allergy Clin Immunol, 138, pp.639~652 (2016)
- Thorburn AN, "Harnessing regulatory T cells to suppress asthma : from potential to therapy", Am J Respir Cell Mol Biol, 43, pp.511~519 (2010)
- Mamessier E, "T-cell activation during exacerbations : a longitudinal study in refractory asthma", Allergy, 63, pp.1202~1210 (2008)
- Kearley J, "Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4＋CD25＋ regulatory T cells is interleukin 10 dependent", J Exp Med, 202, pp.1539~1547 (2005)
- Liao W, "IL-2 family cytokines : new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation", Curr Opin Immunol, 23, pp.598~604 (2011)
- Boyman O, "Selective stimulation of T cell subsets with antibody-cytokine immune complexes", Science, 311, pp.1924~1927 (2006)
- Spangler JB, "Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms", Immunity, 42, pp.815~825 (2015)
- Webster KE, "In vivo expansion of T reg cells with IL-2-mAb complexes : induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression", J Exp Med, 206, pp.751~760 (2009)
- Smaldini PL, "Systemic IL-2", anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells, 2018, pp.73, 885~895
- Wilson MS, "Suppression of murine allergic airway disease by IL-2 : anti-IL-2 monoclonal antibody-induced regulatory T cells", J Immunol, 181, pp.6942~6954 (2008)
- Roediger B, "Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells", Nat Immunol, 14, pp.564~573 (2013)
- Roediger B, "IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation", J Allergy Clin Immunol, 136, pp.1653~1663 (2015)[DOI]
- Wesolowska-Andersen A, "Airway molecular endotypes of asthma : dissecting the heterogeneity", Curr Opin Allergy Clin Immunol, 15, pp.163~168 (2015)
- Kim YS, "Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways", J Immunol, 183, pp.5113~5120 (2009)
- Whitehouse G, "IL-2therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors", Proc Natl Acad Sci U S A, 114, pp.7083~7088 (2017)
- Kim JM, "Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice", Nat Immunol, 8, pp.191~197 (2007)
- Laurence A, "Interleukin-2 signaling via STAT5 constrains T helper 17cell generation", Immunity, 26, pp.371~381 (2007)
- Yang XP, "Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5", Nat Immunol, 12, pp.247~254 (2011)
- Olson MR, "Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production", J Immunol, 198, pp.4352~4359 (2017)
- Kagami S, "Stat5a regulates T helper cell differentiation by several distinct mechanisms", Blood, 97, pp.2358~2365 (2001)
- Das J, "A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation", Nat Immunol, 2, pp.45~50 (2001)
- Garcia S, "Following the development of a CD4 T cell response in vivo : from activation to memory formation", Immunity, 11, pp.163~171 (1999)
- Fallon PG, "Identification of an interleukin(IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion", J Exp Med, 203, pp.1105~1116 (2006)
- Oliphant CJ, "MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+)T cells potentiates type 2 immunity and promotes parasitic helminth expulsion", Immunity, 41, pp.283~295 (2014)
- 홍성욱, "Beyond Hygiene: Commensal Microbiota and Allergic Diseases", Immune Network, 17(1), pp.48~59 (2017), 대한면역학회[DOI]
- Trompette A, "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis", Nat Med, 20, pp.159~166 (2014)
- Lloyd CM, "Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis", J Immunol, 166, pp.2033~2040 (2001)